Moreover, miR-221/222 overexpression is linked to liver tumorigenesis from normal liver through cirrhosis to full-blown hepatocellular carcinoma (HCC), and miR-221/222 can enhance cell growth by targeting the cyclin-dependent kinase inhibitor p27 (72, 73). This evidence concerns the gene CDKN1B and hepatocellular carcinoma.